Literature DB >> 23914926

Biochemical characterization of the γ-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis, PgiCA.

Sonia Del Prete1, Viviana De Luca, Daniela Vullo, Andrea Scozzafava, Vincenzo Carginale, Claudiu T Supuran, Clemente Capasso.   

Abstract

Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze a simple but physiologically relevant reaction in all life kingdoms, carbon dioxide hydration to bicarbonate and protons. CAs are present in many pathogenic species and are involved in the bicarbonate metabolism/biosynthetic reactions involving this ion. Ubiquity of these enzymes suggests a pivotal role in microbial virulence and pathogenicity. Porphyromonas gingivalis is an anaerobic bacterium, which colonizes the oral cavity, being involved in the pathogenesis of periodontitis, an inflammatory disease leading to tooth loss. Recently, we reported an anion inhibitory study on the γ-CA (denominated PgiCA) identified in the genome of this Gram-negative bacterium. In this paper we continue our research on PgiCA, and describe the biochemical characterization of the recombinant protein, its thermal stability, the oligomeric state and the enzyme kinetics. PgiCA is a polypeptide chain formed of 192 amino acids and displays an identity of 30-33% when compared with the prototypical γ-CAs, CAM or CAMH (from Methanosarcina thermophila) or CcmM (from Thermosynechococcus elongatus). A subunit molecular mass of 21 kDa was estimated by SDS-PAGE, while HPLC size exclusion chromatography under native conditions gave an estimated molecular mass of 65 kDa suggesting that the recombinant enzyme self-associate in a homotrimer, as all other γ-CAs studied so far. Enzyme kinetic analysis showed that PgiCA is 62 times more effective as a catalyst compared to CAM, the only other γ-CA characterized in detail kinetically. All these features represent an interesting attractive for the drug design of inhibitors/activators of this new enzyme.

Entities:  

Keywords:  CO2 hydration; enzyme kinetic; metalloenzymes; periodontitis; γ-carbonic anhydrase

Mesh:

Substances:

Year:  2013        PMID: 23914926     DOI: 10.3109/14756366.2013.822371

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  6 in total

Review 1.  Legionella pneumophila Carbonic Anhydrases: Underexplored Antibacterial Drug Targets.

Authors:  Claudiu T Supuran
Journal:  Pathogens       Date:  2016-06-16

Review 2.  Carbonic Anhydrase from Porphyromonas Gingivalis as a Drug Target.

Authors:  Claudiu T Supuran; Clemente Capasso
Journal:  Pathogens       Date:  2017-07-15

3.  Activation Profile Analysis of CruCA4, an α-Carbonic Anhydrase Involved in Skeleton Formation of the Mediterranean Red Coral, Corallium rubrum.

Authors:  Sonia Del Prete; Daniela Vullo; Didier Zoccola; Sylvie Tambutté; Claudiu T Supuran; Clemente Capasso
Journal:  Molecules       Date:  2017-12-28       Impact factor: 4.411

4.  Overexpression and Purification of Gracilariopsis chorda Carbonic Anhydrase (GcCAα3) in Nicotiana benthamiana, and Its Immobilization and Use in CO2 Hydration Reactions.

Authors:  Md Abdur Razzak; Dong Wook Lee; Junho Lee; Inhwan Hwang
Journal:  Front Plant Sci       Date:  2020-11-19       Impact factor: 5.753

5.  In Silico Investigation of Potential Applications of Gamma Carbonic Anhydrases as Catalysts of CO2 Biomineralization Processes: A Visit to the Thermophilic Bacteria Persephonella hydrogeniphila, Persephonella marina, Thermosulfidibacter takaii, and Thermus thermophilus.

Authors:  Colleen Varaidzo Manyumwa; Özlem Tastan Bishop
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

6.  Inhibition of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with aromatic sulphonamides and clinically licenced drugs - a joint docking/molecular dynamics study.

Authors:  Alessandro Bonardi; Alessio Nocentini; Sameh Mohamed Osman; Fatmah Ali Alasmary; Tahani Mazyad Almutairi; Dalal Saied Abdullah; Paola Gratteri; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.